InMed Pharmaceuticals Inc (INM) support and resistance · rev $4.9M
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
This page maps InMed Pharmaceuticals Inc (INM) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
INM currently screens at market cap $5.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new INM 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the INM quote page for the session range and the stock page for the full model.
Not investment advice.